Assignee
SANOFI PASTEUR
FR·24 granted patents·28 pending applications·40 citations·filing 2004–2025
Top patents by PatentIndex Score
52 records- 0194US7641907B2Dengue serotype 1 attenuated strainSANOFI PASTEUR·Filed 2006·Granted Jan 5, 2010·16 cites·10 claims
- 0293US7641908B2Dengue serotype 2 attenuated strainSANOFI PASTEUR·Filed 2006·Granted Jan 5, 2010·17 cites·10 claims
- 0372US2023277655A1Human Cytomegalovirus Immunogenic CompositionSANOFI PASTEUR·Filed 2022·Application pending·0 cites
- 0471US11690903B2Compositions for booster vaccination against dengueSANOFI PASTEUR·Filed 2018·Granted Jul 4, 2023·1 cites·22 claims
- 0571US2025019774A1Primers and probes for detecting mycobacteriaSANOFI PASTEUR·Filed 2024·Application pending·0 cites
- 0669US10144940B2Method for producing Haemophilus influenzae type B antigensSANOFI PASTEUR·Filed 2016·Granted Dec 4, 2018·2 cites·35 claims
- 0768US10118951B2Multimerization of recombinant protein by fusion to a sequence from lampreySANOFI PASTEUR·Filed 2015·Granted Nov 6, 2018·1 cites·22 claims
- 0868US9937252B2Induction of cross-reactive cellular response against rhinovirus antigensSANOFI PASTEUR·Filed 2014·Granted Apr 10, 2018·1 cites·15 claims
- 0966US9028839B2Stabilizing excipient for inactivated whole virus vaccineSANOFI PASTEUR·Filed 2013·Granted May 12, 2015·1 cites·23 claims
- 1066US2015031857A1Dengue serotype 2 attenuated strainSANOFI PASTEUR·Filed 2014·Application pending·0 cites
- 1165US11207403B2Human cytomegalovirus immunogenic compositionSANOFI PASTEUR·Filed 2020·Granted Dec 28, 2021·0 cites·13 claims
- 1264US11524069B2Human cytomegalovirus immunogenic compositionSANOFI PASTEUR·Filed 2018·Granted Dec 13, 2022·0 cites·20 claims
- 1364US11452772B2Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the sameSANOFI PASTEUR·Filed 2021·Granted Sep 27, 2022·0 cites·15 claims
- 1464US2025228933A1Human Cytomegalovirus Immunogenic CompositionSANOFI PASTEUR·Filed 2025·Application pending·0 cites
- 1561US7507718B2Polymyxin B analogs for LPS detoxificationSANOFI PASTEUR·Filed 2006·Granted Mar 24, 2009·1 cites·77 claims
- 1661US2009104227A1Vaccine composition for the prevention of cmv infectionSANOFI PASTEUR·Filed 2008·Application pending·0 cites
- 1760US2023338504A1Compositions for Booster Vaccination Against DengueSANOFI PASTEUR·Filed 2023·Application pending·0 cites
- 1860US2007087009A1Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonistSANOFI PASTEUR·Filed 2004·Application pending·0 cites
- 1960US2025115881A1Modified vero cells and methods of using the same for virus productionSANOFI PASTEUR·Filed 2023·Application pending·0 cites
- 2058US7871807B2Method for producing the flu virusSANOFI PASTEUR·Filed 2008·Granted Jan 18, 2011·0 cites·19 claims
- 2158US2023366883A1Diagnostic TestsSANOFI PASTEUR·Filed 2023·Application pending·0 cites
- 2258US2023293447A1Cleavable lipidic compounds, compositions containing thereof, and uses thereofSANOFI PASTEUR·Filed 2021·Application pending·0 cites
- 2355US2010111990A1Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected WomenSANOFI PASTEUR·Filed 2008·Application pending·0 cites
- 2454US10577398B2Multimerization of recombinant protein by fusion to a sequence from lampreySANOFI PASTEUR·Filed 2018·Granted Mar 3, 2020·0 cites·20 claims
- 2554US2022328139A1Method for determining at a current time point a preservation state of one product and computer system for carrying out said methodSANOFI PASTEUR·Filed 2020·Application pending·0 cites
- 2653US2014178478A1Immuno-Adjuvant EmulsionSANOFI PASTEUR·Filed 2014·Application pending·0 cites
- 2752US2009203881A1Polymyxin B Analogs for LPS DetoxificationSANOFI PASTEUR·Filed 2009·Application pending·0 cites
- 2851US2025339506A1Compositions for use in treatment of chlamydiaSANOFI PASTEUR·Filed 2025·Application pending·0 cites
- 2950US9982240B2Production of infectious influenza virusesSANOFI PASTEUR·Filed 2013·Granted May 29, 2018·0 cites·15 claims
- 3050US2008107685A1Live Attenuated Dengue 3 Virus StrainsSANOFI PASTEUR·Filed 2007·Application pending·0 cites
- 3150US2023295097A1Lipidic compounds comprising at least one terminal radical of formula -nh-cx-a or -nh-cx-nh-a, compositions containing them and uses thereofSANOFI PASTEUR·Filed 2021·Application pending·0 cites
- 3249US11471521B2Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the sameSANOFI PASTEUR·Filed 2019·Granted Oct 18, 2022·0 cites·12 claims
- 3349US2010291192A1Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteriaSANOFI PASTEUR·Filed 2010·Application pending·0 cites
- 3449US2023398211A1Liposomes Containing TLR4 Agonist, Preparation and Uses ThereofSANOFI PASTEUR·Filed 2021·Application pending·0 cites
- 3547US10772946B2Immunogenic compositions against S. aureusSANOFI PASTEUR·Filed 2016·Granted Sep 15, 2020·0 cites·32 claims
- 3646US9556464B2Method for producing Haemophilus influenzae type B antigensSANOFI PASTEUR·Filed 2013·Granted Jan 31, 2017·0 cites·26 claims
- 3742US2019201517A1Vaccine CompositionsSANOFI PASTEUR·Filed 2018·Application pending·0 cites
- 3841US2006165717A1DCchol in newbornsSANOFI PASTEUR·Filed 2006·Application pending·0 cites
- 3941US2015196631A1Vaccine compositionsSANOFI PASTEUR·Filed 2013·Application pending·0 cites
- 4041US2010247557A1Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 AgonistSANOFI PASTEUR·Filed 2010·Application pending·0 cites
- 4140US10232029B2Compositions comprising N. meningitidis proteinsSANOFI PASTEUR·Filed 2015·Granted Mar 19, 2019·0 cites·31 claims
- 4240US2013028934A1Stabilizer and Vaccine Composition Comprising One or More Live Attenuated FlavivirusesSANOFI PASTEUR·Filed 2012·Application pending·0 cites
- 4339US2015265695A1Vaccine compositions for prevention against dengue virus infectionSANOFI PASTEUR·Filed 2013·Application pending·0 cites
- 4438US12515845B2Internal cardboard support for receiving pharmaceutical products, packaging and method for packagingSANOFI PASTEUR·Filed 2021·Granted Jan 6, 2026·0 cites·17 claims
- 4538US2015273035A1Vaccination against japanese encephalitis, measles, mumps and rubellaSANOFI PASTEUR·Filed 2013·Application pending·0 cites
- 4637US9938055B2Method of storing a vaccine containing an aluminum adjuvantSANOFI PASTEUR·Filed 2015·Granted Apr 10, 2018·0 cites·11 claims
- 4734US12343306B2Ready-to-sell packaging unit containing at least one pharmaceutical product, set including a plurality of such packaging units and method for producing such packaging unitSANOFI PASTEUR·Filed 2019·Granted Jul 1, 2025·0 cites·22 claims
- 4834US2018125961A1Neisseria meningitidis trypsin-like serine protease polypeptides and compositions thereofSANOFI PASTEUR·Filed 2015·Application pending·0 cites
- 4933US2018125960A1Meningitidis vaccines comprising subtilinasesSANOFI PASTEUR·Filed 2015·Application pending·0 cites
- 5032US10946087B2Vaccine compositions against dengue virus diseasesSANOFI PASTEUR·Filed 2015·Granted Mar 16, 2021·0 cites·27 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →